Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
A live webcast of the fireside chat can be accessed on the Investors section of the Abeona website under 'Events' at https://investors.abeonatherapeutics.com/events. The webcast will be archived for 30 days.
About Abeona Therapeutics
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona's ZEVASKYN™ (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company's fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. The Company's development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona's novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. For more information, visit www.abeonatherapeutics.com.
ZEVASKYN™, Abeona Assist™, Abeona Therapeutics®, and their related logos are trademarks of Abeona Therapeutics Inc.
Forward-Looking Statements Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Meta (META) Remains Top Pick Ahead of Q2 Earnings, Says Citi
Meta Platforms, Inc. (NASDAQ:META) ranks among the . Citi analyst Ronald Josey reiterated Meta Platforms, Inc. (NASDAQ:META)'s 'Top-Pick' status ahead of the company's second-quarter earnings on July 15, maintaining the Buy rating and $803 price target. Although it is still up 340 basis points year-over-year, Citi's tracking data indicates that Instagram Sponsored Reels ad load decreased 100 basis points from quarter-to-quarter to 24.9% in Q2 2025. This was the first quarterly dip since the firm began tracking this metric in June 2022. According to Citi, the reason for this quarterly drop in ad load is due to Meta's more recent AI advertising capabilities producing more relevant, customized ads with higher conversion rates. With a growing online advertising landscape as a contributing element, the firm believes Meta Platforms, Inc. (NASDAQ:META) is 'well-positioned to deliver better than expected results' in its upcoming earnings release. Meta Platforms, Inc. (NASDAQ:META) is a renowned technology company known primarily for its flagship platforms Facebook, Instagram, and WhatsApp, as well as its revolutionary advances in augmented reality (AR) and virtual reality (VR). While we acknowledge the potential of META as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Microsoft (MSFT) Price Target Raised on Azure Optimism
Microsoft Corporation (NASDAQ:MSFT) ranks among the . BMO Capital kept its Outperform rating on Microsoft Corporation (NASDAQ:MSFT) and increased its price target from $485 to $550 on July 10. The adjustment came following BMO Capital's consultations with cloud specialists who offered input on Microsoft's Azure cloud platform. In contrast to the March quarter, the firm reported that Azure commentary was 'incrementally positive' during the June quarter. Ken Wolter / Despite an increase in production workloads, BMO Capital observed that Azure service usage stayed 'largely stable' during this time. The firm also noted that 'aggressive VMware pricing' has aided transitions to the cloud. BMO Capital is sticking to its Azure growth projections, which it claims align with consensus projections for Microsoft's fourth quarter, despite the encouraging feedback. Microsoft Corporation (NASDAQ:MSFT) is a leading technology company known for its core software products, which include the Windows OS, Microsoft 365 suite, and Edge browser. Its product portfolio includes corporate software, software development tools, video games, gaming gear, and cloud services. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None.
Yahoo
an hour ago
- Yahoo
Skyworks (SWKS) Unveils New Timing Devices for Data Centers and High-Speed Networks
Skyworks Solutions, Inc. (NASDAQ:SWKS) ranks among the best magic formula stocks to invest in. On June 25, Skyworks Solutions, Inc. (NASDAQ:SWKS) declared the launch of new timing devices intended for use in data centers and high-speed networking. Photo by Yogesh Phuyal on Unsplash These include the SKY62101 ultra-low jitter clock generator, which can generate both Ethernet and PCI Express spread spectrum clocks with 18fs RMS phase jitter performance, and the SKY63104/5/6 family of jitter suppressing clocks. The devices seek to simplify complex clock tree designs by integrating general-purpose clock production, Ethernet, and PCIe into a single component. According to James Wilson, vice president and general manager of Skyworks' Mixed Signal Solutions division, the company's MultiSynth and DSPLL technologies 'set a new benchmark for performance and integration.' Skyworks Solutions, Inc. (NASDAQ:SWKS) creates and produces semiconductor components for use in consumer electronics, telecommunications, automotive, and aerospace. While we acknowledge the potential of SWKS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
